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Abstract-Recent evidence suggests that a strychnine-insensitive glycine modulatory site is associated with 
the N-methyl-D-aspartate receptor-channel complex. A quantitative autoradiographic method was used 
to characterize the pharmacological specificity and anatomical distribution of strychnine-insensitive 
[iH]glycine binding sites in rat brain. [‘H]Glycine binding was specific, saturable, reversible, pH and 
temperature-sensitive and of high affinity. [‘H]Glycine interacted with a single population of sites having 
a KD of approximately 200 nM and a maximum density of 6.2 pmol/mg protein (stratum radiatum, CAI). 
Binding exhibited a pharmacological profile similar to the physiologically defined strychnine-insensitive 
glycine modulatory site. Binding was stereoselective; the rank order of potency of simple amino acids as 
displacers of binding was: glycine > D-serine > D-alanine > L-serine > L-alanine > L-valine > D-Vahe. 
Binding was not altered by the inhibitory glycine receptor ligand, strychnine, by the glutamate agonists, 
quisqualate and kainate, or by GABA receptor selective ligands. Most competitive agonists or antagonists 
of the N-methyl-u-aspartate recognition site were ineffective displacers of glycine binding. The exceptions 
were the aminophosphono series of antagonists, D-alpha-aminoadipate, gamma-D-glutamylglycine and 
beta-D-aspartylaminomethylphosphonic acid. However, the inhibition of [‘Hlglycine binding produced 
by the aminophosphono compounds could be accounted for by the level of glycine contamination 
present in these compounds. The non-competitive NMDA receptorxhannel blockers, phencyclidine, its 
thienyl derivative, and MK-801 did not alter glycine binding. Kynurenate, glycine methylester, L-serine-O- 
sulfate, L-homocysteic acid, and several glycine-containing dipeptides were effective displacers of 
glycine binding. Structureeactivity relations of agonists and antagonists of the strychnine-insensitive 
glycine binding site are discussed. The distribution of strychnine-insensitive [‘Hlglycine binding was 
heterogeneous with the following rank order of binding densities: hippocampus > cerebral cortex z 
caudate-putamen > thalamus > cerebellum > brain stem. This distribution of binding was correlated with 
N-methyl-D-aspartate-sensitive [‘HIglutamate binding (r’ = 0.77; P < 0.001; Pearson product-moment) 
and [‘H]thienylcyclohexylpiperidine binding (rZ = 0.72; P < 0.001). 
These observations are consistent with the hypothesis that the strychnine-insensitive glycine binding site 
is closely associated with the N-methyl-D-aspartate receptor<hannel complex. These data also suggest 
that the stoichiometry between these binding sites is approximately I : 3 : 4 (thienylcyclohexylpiperidine : 
glycine:glutamate) in stratum radiatum of area CAI. However, in other brain regions, there were 
more glycine than glutamate binding sites suggesting that there may be heterogeneity in the N-methyl-D- 
aspartate receptor<hannel complex 
The N-methyl-D-aspartate (NMDA)-subtype of 
glutamate receptors is part of a receptor-ion channel 
complex with multiple regulatory sites including 
$To whom correspondence should be addressed. 
Abbrmiutions: AP5, DL-2-amino-5-phosphonopentanoic acid; 
AP7, DL-2-amino-7-phosphonoheptanoic acid; APB, DL- 
2-amino-4-phosphonobutyric acid; ASP-AMP, beta-D- 
aspartyl-aminomethylphosphonic acid; DGG, gamma- 
D-glutamylglycine; GAMS, gamma-D-glutamylamino- 
methylsulfonate; GDEE, L-glutamyl-diethylester; 
HA-966, 3-amino-I-hydroxypyrollid-2-one; HPLC, high 
pressure liquid chromatography; LGG, gamma-L-glu- 
tamylglycin& L-SOS, L-ser&e:O&lfate; ?$K-801, {(y )- 
5-methyl- IO,1 I-dihydro-SH-dibenzo[a,d]cyclohepten- 
5,10-imine maleate}; NAAG, N-acetyl-L-aspartyl-L- 
glutamic acid: NMDA, N-methyl-D-aspartate; PCP. 
phencyclidine; TCP, N-( I-[2-thienyl]cyclohexy1)3,4- 
piperidine; THA, tetrahydroamino acridine; TLC, thin 
layer chromatography. 
distinct sites for magnesium and zinc, and a channel 
binding site (phencyclidine, PCP receptor) for dis- 
sociative anesthetics and {( + )-S-methyl- lo,1 1 -dihy- 
dro-5H-dibenzo[a,d]cycIohepten-5,10-imine maleate} 
(MK-801). 2’ 22.34 The complex also has a strychnine- 
insensitive glycine binding site.23.27,58 The NMDA 
operated channel is gated by magnesium in a voltage- 
dependent manner.32.36.45 Magnesium also alters 
the binding characteristics of [‘Hltrichloroacetic acid 
([‘HITCP) and [3H]MK-801 to the NMDA associated 
channel.8,52,M Zinc selectively antagonizes NMDA- 
mediated responses at a site distinct from that 
of magnesium. 49.6’ Zinc also inhibits [3H]glutamate 
binding to NMDA recognition sites and reduces 
[3H]MK-801 binding to the channel.““2 
PCP receptor ligands block NMDA responses 
in a non-competitive, activity-dependent manner 
probably by binding within the ion channel.‘,62 
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Modulation of NMDA receptor activation regulates 
[‘H]TCP and [3H]MK-801 binding.’ I’ However, 
reciprocal interactions have not been demon- 
strated.“‘.‘“,’ 
Johnson and Ascher” demonstrated, in outside- 
out patches, that glycine potentiates NMDA- 
induced increases in cation conductance in a 
strychnine-insensitive manner. Following this 
observation. several reports have indicated that 
glycine and structurally-related analogs also poten- 
tiate NMDA-mediated events in other systems: 
cnhancemcnt of NMDA-stimulated electrophysio- 
logical responses,J,“.2’ [‘H]TCP and [‘H]MK-801 
binding,’ ‘i ‘i hi and [‘Hlnorepinephrine release.“’ 
Furthermore. reciprocal interactions between the 
NMDA recognition site and the glycinc modulatory 
site have been described.’ “.“.Q Glycine can stim- 
ulatc agonist binding to the NMDA recognition site 
in membrane homogenates. Furthermore, NMDA 
receptor agonists stimulate [‘Hlglycine binding 
whereas antagonists inhibit [‘Hlglycine binding. 
However, additional studies have demonstrated no 
interaction between glycine and NMDA recognition 
sile~,‘.‘.“l,l 
The anatomical localization of strychnine- 
insensitive [‘Hlglycine sites and the regional relation- 
ship between this site and NMDA recognition and 
PCP sites have not been described in detail. It is 
not clear whether these binding sites are always 
associated or if they can exist independently of one 
another. 
Although there have been previous reports 
of strychnine-insensitive glycine binding in rat 
brain.“.Y_‘: “,~(, we now provide the first detailed 
characterization of the regional distribution and 
pharmacology of glycine binding sites in rat brain 
s&ions using quantitative autoradiography. The 
topography of strychnine-insensitive glycinc binding 
sites is compared with the distribution of NMDA- 
sensitive [‘H]glutamate, and [‘HITCP binding sites. 




[‘H]Glycine was obtained from Amersham (Arlington 
Heights, IL. U.S.A., specific activity = 13.3-19 Cijmmol). 
[IL-2-Amino-4-phosphonobutyric acid (APB). uL-2-amino- 
5.phosphonopentanoic acid (AP5), uL-2-amino-7-phospho- 
ndheptanoic &d (AP7), gamma-o-glutamylamino-methyl- 
sulfonate (GAMS), gamma-u-glutamylglycine (DGG). 
gamma-L-giutamylglyci~e (LGG), L-gl;ta&yl-diethylester 
(GDEE), beta-D-aspartyl-aminomethylphosphonic acid 
(ASPS-AMP), u-homocysteine sulfinic acid, 7-chlorokyn- 
urenate, and 3-amino-1-hydroxypyrollid-2-one (HA-966) 
were obtained from Tocris Neuramin (Essex, U.K.). 
N-Acetvl-L-aspartyl-L-glutamic acid (NAAG) and glycyl- . ..- 
I.-glutamic acid were purchased from Bachem (Torrance, 
CA. U.S.A.). MK-801 was a rift from Dr P. Anderson 
(Merck, Sharp & Dohme, West Point. PA. U.S.A.). TCP 
and PCP were gifts from Dr E. Domino. University of 
Michigan (Ann Arbor. MI. U.S.A.). All other compound\ 
were purchased from Sigma. 
I)I.-AP~. IIL-AP7, kynurenate. glycine methyl ester, 
n-alpha-aminoadipic acid. L-homocysteic acid, ASP AMP. 
and five glycine-containing dipeptides were tested for poss- 
ible glycinc contamination by thin layer chromatography 
(TLC) with acidic (n-butanol:acetic acid:water, I?: 3: 5) 
and basic (ethanol: ammonia : water. 20: 1: 4) solvenl sys- 
tems. Ninhydrin was used to visualize glycine. Additionally. 
I>I.-APS. rj~-AP7. kynurenate. NMDA and glutamate 
were tested for glycine contamination using high pressure 
liquid chromatography (HPLC). Electrochemical detection 
of glycine was carried out using a modification of previously 
described o-phthaldialdehyde derivitization.‘J;‘.“‘,’ Con- 
pounds were examined by HPLC at concentrations 
(100 nM I mM) that allowed detection of at least 0.001”‘0 
glycine contamination. Multiple sources of compounds were 
tested when available. 
Adult malt Sprague Dawley albino rats (three months 
old) were killed by decapitation. The brains were quickly 
removed. frozen on dry ice, and mounted on cryostat 
chucks. Mounted brains were allowed to equilibrate to the 
tcmperaturc of the cryostat (- 12 to -20’C) and 20-/(M 
horizontal sections were cut and thaw-mounted onto 
gelatin-coated slides. Sections were stored at -20 C for 
less than 24 h. Preliminary experiments determined that 
[‘Hjglycine binding was not altered by frozen storage for 
34h. 
Tissue sections were preincubated in 50 mM Tris citrate 
(pH 7.4) at 4 C for 30 min to remove endogenous com- 
pounds and then dried under a stream of cool air. In 
preliminary experiments this length of preincubation was 
determined to maximize [‘Hlglycine binding while maintain- 
mg tissue integrity. Longer preincubation periods of up to 
2 h at 4 C did not further enhance binding. In regional 
distribution studies. sections were then incubated in the 
same buffer (pH 7.4) containing 1OOnM [‘Hlglycine for 
35 min at 4 C (final volume = 8 ml); under these conditions, 
less than 5% of free ligand was bound and “zone A” 
conditions were maintained. In preliminary experiments. 
[‘Hlglycine binding in rat forebrain was found to be insen- 
sitive to the addition of 100pM strychnine. In saturation 
studies. the concentration of [‘Hlglycine was 40 nM and 
varying amounts of unlabeled glycine were included in the 
incubation buffer to give final concentrations of glycine 
ranging from 41 nM to 2.5 PM. Non-specific binding was 
determined in the presence of I mM unlabeled glycine and 
represented less than 10% of total binding at a concen- 
tration of 100 nM [?H]glycine.” 
Following the incubation, sections were rinsed three time, 
with 2 ml ice-cold buffer followed by a final rinse with 2 ml 
Ice-cold glutaraldehyde (49%): acetone mixture (1: 19 v/v) 
and quickly dried under a warm stream of air to minimize 
uneven ligand dissociation. Preliminary experiments deter- 
mined that this rinse procedure optimized the ratio of 
specific to non-specific binding. Maximum rinse time wa\ 
less than 5 s. 
Tissue sections were apposed to tritium-sensitive tilm 
(LKB Ultrofilm ‘H) for two to six weeks. A set of radio- 
active standards (American Radiochemicals, ARC c’l4) 
calibrated against whole brain pastes with known amounts 
of protein--tritium was exposed with each film. Protein 
values of whole brain paste sections were determined by the 
Lowry method. Quantitative analysis of the resulting auto- 
radiograms was performed densitometrically using a micro- 
computer based video densitometer system (Imaging 
Research. St Catherines. Ontario). Optical density values 
Strychnine-insensitive glycine binding sites 655 
were converted to pmol/mg protein using a computer gener- 
ated polynomial regression analysis which compared film 
densities produced by the tissue sections to those of radioac- 
tive standards. 47 Ten readings per area, bilaterally, were 
averaged in triplicate sections from at least three animals. 
Values are expressed relative to protein and represent the 
mean k S.E.M. unless otherwise stated. 
N-MethL’I-o-aspartate-sensitive [‘H]glutamate binding 
NMDA receptors were labeled with [3H]glutamate under 
conditions which select for binding to NMDA receptors.” 
Briefly, following a 30-min pre-rinse, sections were incu- 
bated with 200 nM [ZH]glutamate plus 2.5 PM quisqua- 
late in 50 mM Tris-acetate, pH 7.4, at 4°C. Sections were 
rinsed three times with 2ml of buffer and once with a 
glutaraldehydeeacetone solution. 
[3H] Thienylcyclahexylpiperidine binding 
PCP receptors were labeled with 20 nM [)H]TCP in 
50mM Trisacetate in the presence of I mM Mg2+ at 4°C 
for 45 min, following a 30-min pre-rinse.23 One milh- 
molar Mg’+ maximizes [jH]TCP binding in frozen rat 
brain sections.8 Using this method, binding equilibrium 
is achieved by approximately 45 min in the presence of 
I mM Mg’+. Sections were rinsed 3 x 1 min with ice-cold 
buffer. 
Data analysis 
~q,, values for competitors were calculated by logit-log 
analysis. K, values were determined by the method of Cheng 
and Prusoff’ using the formula K, = rc,/(l + ([L]/K,)). 
Glycine, NMDA and PCP receptor binding distributions 
were compared with the Pearson product-moment co- 
efficient and linear regression analysis. 
RESULTS 
Effects of’ temperature, pH and incubation bufer on 
strychnine-insensitive [‘Hlglycine binding 
Binding to the strychnine-insensitive glycine site in 
hippocampal area CA1 was reduced by raising the 
temperature from 4 to 37°C. Relative to 4°C binding 
at 23°C was reduced by 52 f 6%. Incubation at 37°C 
reduced binding by 68 + 8%. 
Strychnine-insensitive glycine binding was very 
sensitive to changes in pH (Fig. 1). Specific binding 
of [3H]glycine was studied at 10 pH values ranging 
from 4.0 to 10.0. Binding in the stratum radiatum of 
CA1 was optimal in the narrow pH range 7.0-7.5. 
Effect of pH on strychnine-insensitive [‘Hlglycine 
binding in stratum radiatum of the CA1 hippocampal 
subfield. Rat brain sections were incubated with 1OOnM 
[Hlglycine (4°C) in 50 mM Trisscitrate at the pH indicated. 
Data represent specific binding (mean k S.E.M., n = 3). 
Fig. 2. Time dependence and reversibility of strychnine-in- 
sensitive [3H]glycine binding in stratum radiatum of the CA1 
area in rat brain sections. Sections were incubated at 4°C 
with 100 nM [3H]glycine for various times. At 60min, 
dissociation was initiated by “infinite dilution” (arrow). 
Data represent specific binding (binding displaceable by 
I mM unlabeled glycine) and are expressed as 
mean & S.E.M. (n = 3) in terms of pmol/mg protein. 
Specific binding decreased faster at acidic rather than 
alkaline pH values; there was no specific binding at 
a pH value of 5. In contrast, at a pH value of 10 
binding was reduced by 30%. 
The effects of three buffers on strychnine-insensi- 
tive glycine binding were evaluated: Triscitrate, 
Tri-acetate and Tris-HCl (pH 7.4). Tris-base 
(50 mM) was used in each of the three buffer systems. 
Specific equilibrium binding in stratum radiatum of 
CA1 was greatest in Tris-citrate buffer and was, in 
comparison, reduced by 11 f 5% in Tris-acetate 
buffer and by 19 + 4% in HCl buffer. The qualitative 
distribution of glycine binding under each of the 
buffer conditions was similar. 
Kinetics of‘ strychnine-insensitive [3H]glycine binding 
At a concentration of 100 nM [3H]glycine, binding 
in the stratum radiatum of the CA1 area in rat brain 
reached equilibrium rapidly at 4°C and remained at 
equilibrium for at least 2 h (Fig. 2). Dissociation of 
glycine binding (by infinite dilution) was very rapid 
with a rate constant of 0.76/min. The half-time for 
receptor-ligand dissociation was approximately 
0.92 min. Since the dissociation of glycine was very 
rapid, the association rate constant was determined 
to be 2.05 x 106/M per min assuming second order 
kinetics. These rate constant values indicate a dissoci- 
ation constant (K,) value of 369 f 41 nM in the 
stratum radiatum of hippocampal area CAl. 
Saturation of strychnine-insensitive glycine binding 
Saturation experiments were performed over the 
range of 40nM-2.5pM glycine (Table 1; Fig. 3). 
Scatchard transformation of the saturation isotherm 
demonstrated maximal binding (B,,,) of 6.2 f 0.04 
pmol/mg protein (stratum radiatum of CAl) to a 
single population of sites with a KD of 196 f 14 nM 
(Fig. 3 inset). The Hill coefficient from this data was 
0.96 & 0.02 indicating no cooperativity between sites. 
The discrepancy between K, determination by kinetic 
experiments and the equilibrium KD value (Fig. 3) 
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.Table I. Regional comparison of parameters of strychnine- 
insensitive [‘Hlglycine bindmg 
B 111.1, 
Region K,, (nM) ( pmol:mg protein) Hill 
SR CAI 196 * IO 6.2 i 0.04 0.96 * 0.02 
SK CA3 I98 * 73 4.6 i 0.4 0.97 & 0.05 
SMDG l69i 17 4.3 * 0.2 I .o I * 0.03 
Mcd-CPu 200 * IO 2.9 & 0.04 I .04 * 0.07 
(‘ICX 250 * Ih 4.9 * 0.3 I .03 * 0.03 
AV THAL 213 i 2X 3.6 + 0.3 0.96 + 0.01 
Parameters of strychnine-insensitive [‘Hlglycine equilibrium 
binding in six brain regions were determined by 
Scatchard analysis of saturation isotherms. Rat brain 
sections were incubated with 40 nM [‘Hlglycine in the 
presence of I nM to 2.5,~M unlabeled glycine at 4 C 
for 35 min as described in Experimental Procedures. 
Values represent specific binding and are presented as 
mean + S.E.M. (II = 3). There were no significant differ- 
cnces between regional K,, values. SR. stratum radiatum: 
SMDG. stratum moleculare dentate gyrus; Med-CPU. 
medial caudate putamen: CICX. layers 1. II cingulate 
cortex: AV THAL, anterior tentral thalamus. 
probably reflects the ditfculty in accurately determin- 
ing the association rate constant due to fast dissocia- 
tion of glycine. Similar K, values were obtained in 
other brain regions (Table I ). 
The level of glycine contamination in commer- 
cial compounds as assessed by either thin layer 
chromatography or high pressure liquid chromatog- 
raphy varied considerably between compounds. 
Less than 0. I % glycine contamination was present 
in the majority of compounds tested. However, 
I)L-AP5 (from two sources) contained approximately 
1% glycine. NMDA and glutamate were also con- 
taminated with low levels of glycine (O.Ol-0.1%). 
Fig. 3. Representative saturation isotherm and Scatchard 
analysis (inset) of strychnine-insensitive glycine equilibrium 
binding in stratum radiatum of the CAI hippocampdl 
subtield. Rat brain sections were incubated with 40nM 
[‘Hlglycine in the presence of I nM to 2.5 /cM unlabeled 
glycine at 4 C for 35 min as described in Experimental 
Procedures. Each point represents specific binding (total 
binding minus binding present in adjacent sections incu- 
bated in the presence of I mM unlabeled glycine). The 
experiment was repeated six times in six animals with similar 
results. Averaged data represent mean + S.E.M. 
130, 
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Fig. 4. EfTects of magnesium and zmc ions on strychnine- 
insensitive [‘Hlglycine binding in stratum radiatum of the 
CA I hippocampal area. Data are mean + S.E.M. (17 : 3). 
All compounds were tested at a single concen- 
tration of 100 /J M (unless stated otherwise) for their 
ability to alter strychnine-insensitive [‘Hlglycinc 
binding (100 nM [‘Hlglycine). Values represent the 
mean & S.E.M. of three animals and were taken from 
stratum radiatum of hippocampal area CAI (Fig. 4 
and Tables 2 and 3). 
Distinct binding sites on the NMDA rcccptor~ 
channel complex have been described for the cations. 
magnesium and zinc. The diff‘erential effects of these 
two ions on specific strychnine-insensitive glycine 
binding is illustrated in Fig. 4. Magnesium enhanced 
[‘Hlglycine binding over the concentration range, 
0. I IO mM (P < 0.05, ANOVA). Binding was maxi- 
mally increased to I20 + 7% of control at IO mM 
magnesium. Binding was slightly reduced at IO ii M 
magnesium. In contrast. zinc inhibited glycine bind- 
ing over the concentration range of 10 PM-- IO mM 
(P < 0.005, ANOVA). Ten millimolar zinc maximally 
reduced binding to 68 k 3% of the control value. 
Table 2. Competition for strychnine- 
insensitive (‘Hlglycine binding sites in 
stratum radiatum of CA1 by glycinc 
and structurally related amino acids 
Displacer K, (I’M) S.E.M. 
Glycine 0. I3 0.02 
0.Serinc 0.i.s 0.02 
I>-Alanine 0.53 0.14 
I.-Serinc 16.37 3.21 
I -Alaninc 46.12 x.43 
L-Valinc 4.24 mM I .42 
rl-Valine > IO mM 
Values represent mean t S.E.M. 
01 = 3). Assays were performed 
using 100 nM [‘Hlglycine as 
described in Experimental Pro- 
cedures. K, values were determined 
assuming a K,, of I98 nM for 
glycine. 
Strychnine-insensitive glycine binding sites 
Table 3. Pharmacological profile of strychnine-insensitive [lH]glycine binding 
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Percentage inhibition or stimulation of 
strychnine-insensitive [-‘H]glycine binding 
Compounds tested (100 PM) Mean S.E.M. *P-value 
-44.43 6.15 0.001 
-61.96 4.67 0.001 
-35.04 2.22 0.002 
43.44 8.49 0.038 
-83.07 5.1 0.00 I 
- 26.48 6.2 0.014 





-60.37 8.49 0.005 
-80.21 6.41 0.001 
-99.07 3.59 0.001 
-93.97 3.5 0.001 




















Glutamate receptor antagonists 
Kynurenate 
uL-2-Amino-4-phosphonobutyric acid (APB) 
Non-active compounds 
gamma-o-Glutamylaminomethylsulfonate (GAMS) 
L-Glutamyl-diethyl ester (GDEE) 










Amino acid-containing compounds 
u-alpha-Aminoadipic acid 


















L-Cysteine sulfonic acid 
L-Glutamic acid 
Homocarnosine sulfate 
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Percentage inhibiti or stimu~ltion of 
strychnine-insensitive [‘H]giycine binding 
Compounds tested ( IO0 p M) 




‘Y-Benzovl-d-amino valeric acid 
t)L-2.4-Diaminobutyric acid 
Mea11 S.E.M. *P -VdlK 
Data represent mean _+ S.E.M. (II = 3) and are expressed as percentage stimulation or inhibition (-) of 
binding in the presence of displacer relative to the amount of binding in the absence of displacer. 
All readings were taken from stratum radiatum of the CA 1 hippocampa~ area. Binding assays were 
performed as described in Experimental Procedures using 100 nM t’H]gfycine. All displacers were present 
at single lOO/lM concentrations. Statistical comparisons were made by one-way ANOVA, binding in 
presence of displacer vs total binding (non-active compounds produced non-significant alterations in 
[“Hlglycine binding. i.c. P z 0.05). See Refs 24. 37. 46. 60 for review of the pharmacology of some 01 
these compounds. 
The potencies of glycine and both the u- and 
L-isomers of serine, alanine and valine are presented 
in Table 2. Of these amino acids, giycine was the most 
potent inhibitor of strychnine-insensitive glycine 
binding with a K, value of 0.13 k 0.02 I’M. In general 
the D-amino acid isomers were more potent than the 
corresponding L-forms. The rank order of potency 
in displacing glycine binding was: glycine > D-serine 
> n-aianinc > L-serine > I.-alanine > I.-valine > 
o-vaiine. All these amino acids produced complete 
inhibition of glycine binding with the exceptions 
of u- and L-valine which were only evaluated up 
to concentrations of IOmM. All Hill coefficients 
were near unity. The potencies of these ammo acids 
as displacers of [‘H]glycine binding in our assay 
wcrc highly corrclatcd with their ability to inhibit 
strychnine-insensitive [‘Hlglycine binding in homo- 
genate studies’X.Fh.“’ (r2 > 0.82; P < 0.01: Pearson 
product-moment). enhance NMDA-stimulated 
tXH]TCPSh (t.? = 0.98; P < 0.01) and [‘H]MK-~01~~ 
(I.’ = 0.92; P < 0.01) binding in membranes, and 
stimulate NMDA-mediated [‘Hlnorepinephrine re- 
lease in whole brain sections”’ (r’ = 0.83; P < 0.01). 
However. much higher concentrations (eight to 40 
times greater) were necessary to enhance NMDA- 
mediated [~H]norepinephrine release.“’ 
Strychnine, an antagonist at the inhibitory glycine 
receptor, did not alter glycine binding at 100 HIM. 
In contrast, beta-alanine significantly reduced strych- 
njne-insensitive gtycine binding by 44 I): 6% at a 
concentration of 100 FM (P < 0.001 vs total binding, 
ANOVA). 
Of the ligands that bind to the NMDA rcccptor- 
operated ion channel, only tetrahydroam~noacridine 
(THA) significantly affected strychnine-insensitive 
glycine binding; 100 PM THA enhanced glycine 
binding by 43%. In contrast, similar concentrations 
of the dissociative anesthetics PCP and its thienyl 
derivative, TCP. did not alter glycine binding. An 
effect of MK-801 was also absent, The selective, high 
affinity, competitive NMDA antagonist, CPP. did 
not alter binding. In contrast, the aminophosphono 
series of compounds significantly reduced glycine 
binding. The rank order of effectiveness of these 
compounds in inhibiting glycine binding, at a single 
HA-966 and 7-chiorokynurenate. two competi- 
tive antagonists of the strychnine-insensitive glycine 
site.‘“.‘h inhibited ]‘H]glycine binding in a dose- 
dependent manner (Fig. 5). In stratum radiatum of 
CA I. 7-chlorokynurenate was 41 times more potent 
than HA-966 in inhibiting [‘Hfglycine binding; K, 
values were 0.27 + 0.03 !tM (7-chlorokynure~te) 
and I I. 1 1 i 0.89 ,U M (HA-966). Hill coefficients were 
near unity indicating that these ligands are acting at 
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Fig. 5. Dispiacement of strychnine-insensitive [rH]glycine 
binding by two competitive antagonists. 7-chlorokynurenate 
and HA-966. Sections were incubated with IOOnM 
[‘Hlglycine at 4 C in the presence of various concentrations 
of competitors. Measurements were made in stratum radia- 
turn of hippocampal area CAI. Data are mean & S.E.M. 
(If = 4). 
Strychnine-insensitive glycine binding sites 659 
100 p M concentration, was DL-APS > DL-API > 
DL-AP4 (-62 & 5%, -35 + 2%, -26 * 6%; vs total 
binding, P < 0.05, ANOVA). Additionally, the 
amino acid-containing NMDA antagonists, D-alpha 
aminoadipate, ASP-AMP, and gamma-D-glutamyl- 
glycine all produced greater than 50% inhibition 
of glycine binding. Of these compounds, gamma-D- 
glutamylglycine was the most effective displacer of 
binding (binding was reduced by 80%). The L-isomer 
of glutamylglycine completely displaced glycine 
binding. The non-selective glutamate receptor antag- 
onist, kynurenate, significantly antagonized glycine 
binding, displacing 83% of binding at a 100 LAM 
concentration (P < 0.001, ANOVA). Two additional 
antagonists with selectivity favoring non-NMDA 
receptors, CAMS and GDEE, did not alter binding. 
lT&ct of’ glutamate receptor agonists 
Neither L-glutamate nor D- and L-aspartate 
affected strychnine-insensitive [‘Hlglycine binding 
significantly although trends suggested that the 
D-form of aspartate, in comparison to the L-isomer, 
produced a greater reduction in binding. None of 
the prototypic selective glutamate receptor-subtype 
agonists altered glycine binding. However, the 
NMDA agonists, L-homocysteic acid and L-serine-O- 
sulfate, both significantly reduced binding by 45 and 
63%. respectively (P < 0.03, ANOVA). 
l?flkct of amino acid-containing compounds 
With the exception of the simple amino acids 
described above, none of the other amino acids tested 
altered glycine binding. Of note, taurine, which has 
been demonstrated to inhibit high affinity glycine 
uptake in the rat forebrain, does not displace strych- 
nine-insensitive [‘Hlglycine binding. The methyl ester 
derivative of glycine completely inhibited glycine 
binding. 
In addition to the amino acid-containing com- 
pounds above, several dipeptides also significantly 
reduced binding. Glutamyl- and aspartyl-glycine 
both reduced binding by greater than 80% while 
N-glycylglycine only reduced binding by 62% 
(P < 0.001. ANOVA). 
Efltict of GABA receptor ligands 
None of the GABA derivatives tested significantly 
altered strychnine-insensitive glycine binding at con- 
centrations of 100 PM. 
Regional distribution qf‘ strychnine -insensitice glycine 
binding sites 
Strychnine-insensitive glycine binding to rat brain 
sections exhibited a marked regional heterogeneity, 
with the highest binding density present in the 
stratum radiatum of the CA1 hippocampal subfield 
(Table 4 and Fig. 6). Essentially all brain regions 
showed strychnine-insensitive glycine binding. Within 
laminated structures, dendritic zones generally 
had the greatest density of binding with less binding 
in cellular layers. In general, binding decreased 
at caudal levels of the neuroaxis. Within the tel- 
encephalon, the rank order of binding density was 
hippocampal formation > cerebral cortex > olfactory 
nuclei > basal ganglia > diencephalic nuclei. Mid- 
brain structures exhibited the least amount of binding 
and the cerebellum was intermediate. 
Within the olfactory bulb, a distinct laminar distri- 
bution of glycine binding was present (Fig. 6b); the 
greatest density of binding was in the external plexi- 
form layer (43% of maximum), intermediate levels in 
the internal granule layer, and lowest density in the 
glomerular layer. In addition to the high binding 
density in the olfactory bulb, the medial and lateral 
olfactory nuclei also exhibited a high degree of 
binding (75% of the maximum density of glycine 
sites). 
Cerebral cortical regions demonstrated moderate 
to high levels of binding. The density of binding 
varied widely within cortical layers with greatest 
variation between different cortical regions (up to 
two-fold). Generally, binding density decreased from 
superficial to deep cortical layers with the homo- 
geneous distribution pattern present in the entorhinal 
cortex being the exception. Of the cortical regions, the 
cingulate had the highest binding density and the 
frontal and frontoparietal regions exhibited lower 
levels of glycine binding. 
The basal ganglia also revealed a heterogeneous 
pattern of binding. Binding was greatest in the cau- 
dateeputamen, moderate in nucleus accumbens, and 
low in globus pallidus. Very little binding was present 
in the entopeduncular nucleus. Marked variation in 
binding was also observed within these structures. In 
the corpus striatum. 69% of maximal CAI binding 
was present in the ventral posterior region, 55% 
ventroanteriorally, 44% dorsomedially, and 38% 
dorsolaterally. In addition, binding densities in the 
posterior globus pallidus were nearly three times that 
present more anteriorally. The lateral septum exhib- 
ited 43% of maximal CA1 binding while less binding 
was present in the other basal forebrain structures. 
In general, the diencephalic nuclei had moderate 
levels of [‘Hlglycine binding. Various nuclei were 
readily distinguished by the amount of glycine bound. 
The medial dorsal nucleus had the greatest density of 
binding, and the habenula contained the fewest bind- 
ing sites. The anterior ventral, ventral lateral and 
ventral posterior medial nuclei possessed equivalent 
levels of binding (46% maximum). The medial and 
lateral geniculate were readily distinguishable with 
slightly higher binding in the former. Binding in the 
nucleus reunions was only 35% of maximum. 
The hippocampal formation exhibited a very 
distinctive laminar distribution of glycine binding 
(Fig. 6a) that was similar to the topography of 
NMDA-sensitive glutamate binding (Fig. 7).‘xJ’JZ 
The maximal density of binding sites observed any- 
where in the brain was found in the stratum radiatum 
of area CAI. Within the hippocampus, levels were 
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Table 4. Regronal distribution of strychnine-lnseclsitive [‘Hlglycine binding sltcs 1n rat braln 
[‘H]Glycine bound (fmol:mp protein) 
Brain region Abbrcwations 
Mean 
(II = 4) S.E.M. 
Olfactory region 
Glomerular layer 
External plexiform layer 
Internal granule layer 
Medial anterior olfactory nucleus 
Lateral anterior olfactory nucleus 
Primary olfactory cortex 
Cortex 
Entorhinal. layers I and II 
Entorhinal, layer IV 
Entorhinal. layers V and VI 
Frontoparietal. layers I and II 
Frontoparietal. layer IV 
Frontoparietal. layers V and VI 
Frontal. layers 1 and II 
Frontal. layer IV 
Frontal. layers V and VI 
Cingulate. layers 1 and II 
C‘ingulate. layers V and VI 
Basal ganglia 
Caudate~ putamcn. medial 
Caudate putamen. lateral 
Caudate~ putamen, anterior 
Caudatc putamen, posteriol 
Globus pallidus. anterio! 
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CA I. stratum lacunosum moleculare 
CA I. stratum radiatum 
c‘4 I. stratum pyramidale 
CA I 1 stratum oriens 
C‘A3. stratum radiatum 
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Values arc presented as the mean k S.E.M. (II = 4) and as a percentage relative to stratum radiatum 
of the CAI hippocampal subfield. [‘H]Glycine concentration was 100 nM. Autoradiography and 
quantitation of autoradiograms were performed as described in Experimental Procedures. 
greater in CAI than in CA3 and lowest in the hilus. oriens > stratum pyramidale. Eighty-nine per cent 
The rank order of binding densities within CAI of maximal binding was present in the stratum mol- 
and CA3 subfields was stratum radiatum > stratum cculare of the dentate gyrus. 
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Fig. 7. Comparison of representative autoradiograms of strychnine-insensitive [JH]glycine binding (A) and 
NMDA-sensitive glutamate binding (B). Glycine binding was carried out using IOOnM [‘Hlglycine as 
described in Experimental Procedures. NMDA-sensitive [3H]glutamate binding was performed with 
200 nM [3H]glutamate in the presence of 2.5 PM quisqualate as described in detail previously.” 
Qualitatively, the distribution of the two binding sites was nearly identical. 
Brainstem structures exhibited low levels of bind- 
ing with the exception of moderate levels present 
in the central gray, the inferior colliculus and in 
the substantia nigra. In the cerebellum, distinct 
laminar binding was observed. Density levels were 
low in the molecular layer which is the Purkinje 
cell dendritic zone. Binding in the granule cell layer 
of the cerebellum was 30% of maximal binding 
density (seven times greater than the molecular 
layer). 
Comparison of the distribution of binding sites com- 
prising the N-methyl-D-uspnrtate receptor-c~hunnrl 
complex 
A representative comparison of the distribution 
of strychnine-insensitive [3H]glycine binding sites and 
NMDA-sensitive [‘HIglutamate binding sites in rat 
brain is illustrated in Fig. 7. Overall, the regional 
distribution of the two sites was qualitatively very 
similar. Linear regression analysis comparing the 
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distribution of strychnine-insensitive [3H]glycine 
binding, NMDA-sensitive [3H]glutamate binding, 
and [3H]TCP binding in 30 brain regions revealed 
a marked degree of concordance using single con- 
centration equilibrium binding values (r* = 0.77, 
P < 0.001, Pearson product-moment, [‘Hlglycine vs 
[3H]glutamate; r’ = 0.73, P < 0.001, [3H]glycine vs 
[‘HITCP). 
As we have previously reported,33 the distribution 
of NMDA-sensitive [‘HIglutamate binding and 
[)H]TCP binding sites in rat brain is nearly identical 
(u’ = 0.91, P < 0.001) with the exception of the cer- 
ebellar granule layer. However, greater variation is 
observed between the distribution of these two bind- 
ing sites and the distribution of strychnine-insensitive 
glycine binding sites. In stratum radiatum of the CA1 
hippocampal subfield, the ratio of maximum binding 
densities obtained from saturation experiments is 
approximately 1: 3.4 : 4, TCP : glycine : glutamate. 
Comparison of single point equilibrium binding 
density ratios reveals a general pattern among brain 
regions. Glycine and glutamate binding ratios are 
presented relative to a TCP binding value of one. In 
contrast to the lower ratio of glycine to glutamate 
binding present in the hippocampal formation and 
cerebral cortical regions, the ratio of glycine to 
glutamate binding in most other brain regions is 
reversed: olfactory structures, 8.5: 7; basal ganglia, 
12: 6.6; basal forebrain structures, 10: 8.6; thalamic 
nuclei, 12.6: 8.6; brainstem structures, 16:9. The 
cerebellar granule layer exhibits the largest ratio of 
glycine and glutamate to TCP binding (60: 50: I). The 
glycine: glutamate binding ratio also varies within 
structures. The ratio in stratum pyramidale of CA1 is 
17: 8, compared with a ratio of 7.6: 8.2 in the same 
layer of area CA3. 
DISCUSSION 
Correspondence to physiologically dejned strychnine- 
insensitive glycine site 
In rat brain sections, [3H]glycine interacts with a 
single population of sites in a saturable and reversible 
manner. The linear Scatchard plots of saturation data 
with corresponding Hill coefficients near unity and 
the displacement studies support binding to a single 
receptor population. The inability of strychnine and 
the relative inability of beta-alanine and taurine to 
displace [3H]glycine binding in our assay distinguishes 
these sites from the classical inhibitory glycine recep- 
tor which is present in high concentrations in spinal 
cord. Furthermore, the kinetics, pharmacological 
selectivity, narrow pH dependency, and regional 
brain distribution of [3H]glycine binding suggest that 
the sites labeled in this study correspond to the 
physiologically defined strychnine-insensitive glycine 
sites. 
Strychnine-insensitive glycine binding sites exhibit 
the appropriate kinetics expected for the physiologi- 
tally defined site. 23~19 The equilibrium dissociation 
constant (&,) derived in this study corresponds well 
with not only the lcsO value for glycine inhibition 
of [3H]glycine binding in the present study, but also 
with EC,, values for glycine enhancement of NMDA- 
mediated [3H]TCP and [3H]MK-801 binding.5’,55 The 
KD value of 198 nM calculated from rat brain sections 
in the present study is nearly identical to values 
reported in membrane homogenate studies.6.‘8 
Strychnine-insensitive glycine binding sites also 
exhibit a ligand specificity indicative of the physio- 
logically defined strychnine-insensitive glycine recep- 
tor. The rank order of potency of glycine and the 
D- and L-isomers of serine, alanine and valine as 
displacers of strychnine-insensitive [3H]glycine bind- 
ing in this study is highly correlated with the ability 
of these ligands to stimulate NMDA-mediated 
[‘Hlnorepinephrine release” and enhance [‘H]TCP 
and [‘H]MK-801 binding in biochemical studies.5h.63 
A similar amino acid profile has been observed 
for enhancement of NMDA-induced conductances 
and NMDA-stimulated calcium influx.“,5’ Further- 
more, the threshold concentration of glycine neces- 
sary to displace [3H]glycine binding is very similar 
to the glycine levels sufficient to enhance NMDA- 
mediated currents in patch clamp studies.‘3,‘9 Except 
for glycine, serine, alanine and valine, none of the 
other simple amino acids were effective displacers 
of [‘Hlglycine binding in agreement with patch 
clamp studies and with previous biochemical 
reports. 5.‘3.50.5’~63 The ability of 7-chlorokynurenate 
and HA-966 to inhibit [‘Hlglycine binding in 
our assay is consistent with their ability to block 
NMDA-responses and limit NMDA-mediated brain 
injury. “~‘6.4’ The ability of several dipeptides to 
inhibit [3H]glycine binding may be related to their 
ability to antagonize NMDA responses.60 Kainate- 
and quisqualate-type glutamate receptor and GABA 
receptor selective ligands failed to displace specific 
strychnine-insensitive glycine binding in agreement 
with previous biochemical and electrophysiological 
studies.3,‘” 
It is unlikely that [3H]glycine binding represents 
an enzymatic or transport binding site*’ or simple 
sequestration since strychnine-insensitive glycine 
binding was maximal at 4°C and was greatly reduced 
at 23 or 37-C. In addition, the KD determined by 
kinetic experiments was similar to equilibrium K, 
suggesting that sequestration is unlikely to play a role 
in binding. Binding was highest in areas where glycine 
uptake is lowest. Furthermore, inhibitors of high 
affinity glycine uptake described in rat forebrain, 
such as taurine, are ineffective displacers of binding. 
Taken together with the evidence described above, 
the high degree of concordance between the distribu- 
tion of strychnine-insensitive glycine binding sites 
and the distributions of [3H]TCP and NMDA- 
sensitive glutamate binding sites strongly suggest that 
the site labelled by [3H]glycine in this study represents 
the physiologically defined receptor. 
Two distinct binding sites on the NMDA recep- 
tor-channel complex have been described for the 
prototypic cations magnesium and zinc. Magnesium 
gates the NMDA channel in a voltage-dependent 
mannerlX’!_‘h.~5 and has also been shown to both 
enhance and inhibit [‘H]TCP and [‘H]MK-801 bind- 
ing depending on the concentration of magnesium 
and the state of channel activation.“,“.“’ Magnesium. 
however, does not altcr NMDA-sensitive gluta- 
mate binding.‘,“’ WC found that concentrations OI 
magnesium from 0.1 to IOmM stimulate glycine 
binding. This concentration range is consistent with 
the concentrations needed to block NMDA associ- 
ated ion channels and alter [?H]TCP and [3H]MK-801 
binding. 
Zinc also selectively antagonizes the NMDA reccp- 
tor channel in electrophysiological. biochemical, and 
ncurotoxicity studies but at a site which is distinct 
from the magnesium binding site.‘i.““” “.” Monahan 
and MicheYJ have shown that I mM zinc antagon- 
izes NMDA-sensitive glutamate binding in mcm- 
branc homogenates. The concentration range of zinc 
that inhibits strychnine-insensitive glycine binding 
( IO jcM~- IO mM) is in the range of concentrations that 
attenuate NMDA neuroexcitation (5 ~~M~~l mM) and 
NMDA-mediated neuronal injury (30 /[M-0.5 mM) 
In cortical and hippocampal cell cultures and reduce 
[‘H]MK-801 binding (I icM_I mM) to rat brain 
membranes, i’):i %I,J’) ‘2 hi The antagonistic action of zinc 
on NMDA-mediated responses and neurotoxicity 
and [‘HIMK-801 binding may be due, in part. to a 
reduction in agonist activity at NMDA and glycinc 
recognition sites. The distribution of zinc containing 
prcsynaptic boutons in rat forebrain (Timm staining 
method) closely parallels the distribution of glycine. 
NMDA and TCP recognition sitcs.ll.JX Staining is 
highest in the hippocampus. cerebral cortex. olfac- 
tory bulb. caudateeputamen and lateral septum, with 
littlc staining present in the brainstcm and cerebel- 
lum. Since high micromolar concentrations of zinc 
may be achieved in the synaptic cleft upon stimu- 
lation. zinc may act as a negative modulator of the 
NMDA receptor-channel if7 Cro.‘.‘5 
Qualitatively, the distribution of glycine, NMDA 
and TCP recognition sites is very similar with the 
following order of binding densities: hippocampus 
> cerebral cortex > caudate-putamen > thalamus 
> cerebellum > brainstem. These data strongly 
suggest. in addition to the physiological evidence 
of interactions between sites,“.“,“,‘-” that these 
sites are closely associated. Saturation data indicate 
that the stoichiometry of these sites is I :3.4:4 
(TCP : glycine : glutamate) in the stratum radiatum of 
the CAI hippocampal subfield. In the majority of 
brain regions the ratio of TCP and NMDA-sensitive 
glutamate binding densities is relatively constant.” 111 
contrast, ratios of strychnine-insensitive glycine bind- 
ing to NMDA-sensitive glutamate binding and TCP 
binding arc much more variable between brain struc- 
turcs. Using single concentration equilibrium binding 
values, TCP: glycine : glutamate binding ratios varied 
from I : 7: 9 in area CA I to I : I3 : 9 in basal ganglia 
and thalamus, and I : 16:‘) in the brainstem. The 
largest discrepancy occurred in the cerebellum 
( I : 60: 50). Since the K,s of these binding sites do 
not vary considerably between brain regions (see 
Results and Table I). the single concentration equi- 
librium values reflect mainly alterations in the 
maximum number of binding sites and are unlikely 
IO reflect different endogenous concentrations of 
(llycinc among various brain regions. The absolute D 
stoichiometric numbers arc only estimates of the 
actual receptor stoichiometry since the single ligand 
concentration : K,) ratios differed between rcceptol 
binding assays [concentration : K,, ratios were: TCP 
( I : I ). glutamate (I : I ). glycinc (1: 2)]. Howcvcr, the 
different ligand concentration : K, ratios do not 
alter the basic conclusion that the receptor stoi- 
chiometry differs between brain regions. These data 
suggest there may be heterogeneity to the NMDA 
receptor-channel complex as has been seen with 
the GABA receptors-channel complexs7.“’ and/or that 
some glycine sites may not be associated with the 
NMDA receptor<hannel complex. The strychnine- 
insensitive glycine site may have several gcnctic forms 
that arc expressed differentially among brain regions. 
FOI- example. a family of nicotinic acetylcholinc 
receptor genes, presumably coding for receptor sub- 
types. has been described that are expressed in differ- 
cnt regions of brain.‘” ‘_ 
In contrast to reports describing reciprocal intcr- 
actions between the NMDA recognition site and the 
strychnine-insensitive glycine modulatory site.” ” “” 
neither selective competitive agonists nor antagonists 
of the NMDA recognition site were effective dis- 
placers of [‘Hlglycine binding in the present study. 
Neither L-glutamate, NMDA, nor quinolinatc at 
100 ~1 M concentrations enhanced vH]glycine bind- 
ing. Another report has demonstrated similar 
results.” We found that the selective competitive 
NMDA antagonisl, CPP. does not produce substan- 
tial inhibition of [-‘H]glycine binding. Determination 
of the allosteric interactions between NMDA and 
glycine binding sites awaits the development of more 
selective glycine antagonists. Since dissociative ancs- 
thctics and MK-801 did not alter glycine binding, it 
appears that there is no direct reciprocal interaction 
between the channel binding site and the strychnine- 
insensitive glycine site. This observation is consistent 
with other reports which demonstrated that dissoci- 
ative anesthetics do not directly affect NMDA- 
\cnsitivc glutamate binding.“‘.‘” 
In contrast to the effect of CPP, the aminophos- 
phone family of compounds (AP4, AP5. AP7) 
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were all effective displacers of glycine binding as 
were several dipeptides (especially those containing 
glycine). However, the inhibition of [3H]glycine bind- 
ing by the amino phosphono compounds can be 
accounted for by the level of glycine contamination 
present in these compounds. HPLC analysis of 
glycine content indicated that APS (from two 
sources; Tocris Neuramin, Sigma) contained approx- 
imately 1% glycine. At IOOpM, DL-APS inhibited 
[“Hlglycine binding by 62%. At this concentration 
of AP5, 1 PM glycine contamination would be 
present. Since the I&, of glycine is 200 nM, this level 
of glycine contamination would be expected to pro- 
duce approximately 80% inhibition of [3H]glycine 
binding. The contamination could account for 
the level of [‘Hlglycine displacement produced by 
100 p M AP5. AP4 and AP7 contained less than 0. I % 
glycine and this level of glycine contamination would 
be expected to inhibit [‘Hlglycine binding by less than 
30% at 1OOpM AP4 or AP7 (accounting for the 
degree of inhibition of binding produced by these two 
compounds). In contrast, the level of glycine present 
in the glycine containing dipeptides (Iess than 0.1%) 
cannot explain the inhibition of PHjglycine produced 
by these dipeptides since they all produced 60-100% 
inhibition of binding at 100 PM concentrations. Most 
other effective displacers of 13H]glycine binding as 
well as inactive compounds (NMDA, glutamate) 
contained low levels of glycine contamination which 
could not account for their effects on [jH]giycine 
binding. 
The problem of glycine contamination of commer- 
cial compounds, water supplies, and glassware may 
complicate the interpretation of studies examining 
the function of excitatory amino acid receptor modu- 
lators. In autoradiographic experiments, endogenous 
glycine in the tissue sections is always an issue despite 
extensive washes. In some patch clamp or binding 
studies using extensively washed membranes where 
glycine contamination is thought to be minimal, the 
levels of glycine in commercial materials becomes 
problematic. The purity of compounds used in stud- 
ies of this modulator site should be considered in the 
interpretation of the results. 
Structural requirements of ~tr~~h~~ne-insensitive 
givcitw receptor ligands 
The structure-activity relations of glycine receptor 
ligands that can be determined from the inhibition 
studies of [‘H]glycine binding in Tables 1 and 2 
confirm and extend results from previous studies 
of structureeactivity relations.s6 The D-forms of 
simple alpha-amino acids are in general more potent 
displacers than the L-forms (about 80 times) of 
strychnine-insensitive glycine binding. This stereo- 
specificity is similar to the structural requirements 
of antagonists of the NMDA recognition site.46 A 
hydrogen on the alpha carbon (glycine), a methylene- 
hydroxyl group (serine), or a methylene-O-sulfate 
group L-serine-O-sulfate (L-SOS) is more active than 
a single methyl group while all compounds with 
aspartate length side chains are not active. Of com- 
pounds with glutamate-length side chains, the order 
of activity with respect to the terminal acid group is 
SO,H > PO, H, > COOH. 
The number of atoms separating the amino and 
carboxyl terminals is also an important factor in 
determining activity at the strychnine-insensitive 
glycine receptor. In comparison to glycine, inter- 
terminal chain lengths greater than one carbon 
reduce (beta-alanine, two carbons) or eliminate 
(GABA, three carbons) activity. This is also true 
for activity of ligands at the NMDA recognition 
site.46,60 
Substitutions of the amino and carboxyl terminals 
are also important determinants of activity. Replace- 
ment of the carboxyl terminal of beta-alanine with a 
sulfonic group (taurine) eliminates activity. In con- 
trast, addition of a methylester moiety to the carboxyl 
terminal of glycine (glycine methylester) maintains 
pronounced activity. Methylation of the primary 
amine of glycine (N-methyl-glycine) eliminates activ- 
ity at the glycine binding site.5’.56 Of note, methyl- 
ation of aspartate (N-methyl-aspartate) increases 
activity at the NMDA receptor, whereas larger 
alkylations decrease activity.4h 
Addition of heteroatoms in the carbon chain con- 
necting the acidic groups appears to be well tolerated. 
Replacement of the methylene group of homocysteic 
acid with an oxygen atom (serine-O-sulfate) main- 
tains activity. Of the dipeptides with glycine at the 
gamma-carboxy terminal the order of potency of the 
acidic terminal of glycine is COOH > PO,H, > 
SO,H. Furthe~ore, dipeptides with glycine at the 
N-terminal are less effective than those with glycine 
at the C-terminal and non-glycine containing dipep- 
tides are not active at all. 
Several common structural features of reported 
antagonists of the strychnine-insensitive glycine site 
imply that comformationally restricted and hetero- 
cyclic structures are important determinants of antag- 
onists of the glycine receptor. These include the 
cyclic anhydric analog of GABA, HA-966,‘4.h0 cyclo- 
leucine,5Sa kynurenate, its analog 7-chlorokynuren- 
ate,lh and two heterocyclic quinoxaline derivatives 
&cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 
6,7-dinitroquinoxaline-2.3-dione (DNQX).‘” The 
common structural features of these glycine receptor 
antagonists include planar conformationat restriction 
and functional groups up to at least four atoms from 
the alpha-amino acid carbon. 
Several other putative antagonists of the NMDA 
recognition site also inhibit strychnine-insensitive 
glycine binding (gamma-D-glutamylglycine, ASP- 
AMP. D-alpha-aminoad~pate, kynurenatef. z4.4ft.h” In
fact, gamma-D-glutamylglycine is more effective 
in inhibiting glycine binding than NMDA-sensitive 
glutamate binding (unpublished observation). The 
effects of these compounds on [‘Hlglycine binding 
cannot be explained entirety by non-competitive, 
allosteric interations with NMDA recognition sites 
&cause the selective NMDA antagonist, CPP, did 
not reduce (‘Hlglycine binding. Furthermore. the 
NMDA agonists. L-SOS and L-homocysteic acid. also 
inhibited [‘Hlglycine binding. Glycinc contamination 
cannot account for the inhibition of[‘H]glycine bind- 
ing produced by these compounds. The structural 
features of the dipeptide-type NMDA antagonists 
indicated above arc consistent with the features ol 
glycinc receptor ligands. particularly the antagonists. 
It is the&ore likely that the structural requirements 
for antagonists of both NMDA and glycine sites 
partially overlap. 
CON(‘I.lISION 
The results presented in this paper provide the first 
detailed information about the regional brain distri- 
bution of strychnine-insensitive [jH]glycine binding. 
The data extend earlier descriptions of the pharma- 
cology of strychnine-insensitive [‘Hlglycine binding 
and demonstrate that this labeled site corresponds to 
the physiologically defined site. The results also indi- 
cate that the stoichiometry between the modulatory 
sites comprising the NMDA rcccptor complex var> 
among brain regions. The preliminary studies of the 
structure--activity relations of’ strychnine-inscnsitivc 
glycine receptor ligands could be of considerable 
value in the development of selective agonists and 
antagonists for the glycine modulatory site. Antag- 
onists of the strychnine-insensitive glycine site may 
prove to be an effective treatment in inherited juvcnilc 
non-ketotic hyperglycinemia”’ as well as other ncuro- 
logic disorders.“,‘X,“‘J’ ” ” 
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